326 related articles for article (PubMed ID: 22411078)
21. Eculizumab treatment of acute antibody-mediated rejection in renal transplantation: case reports.
González-Roncero F; Suñer M; Bernal G; Cabello V; Toro M; Pereira P; Angel Gentil M
Transplant Proc; 2012 Nov; 44(9):2690-4. PubMed ID: 23146495
[TBL] [Abstract][Full Text] [Related]
22. Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience.
Jin MK; Cho JH; Kwon O; Hong KD; Choi JY; Yoon SH; Park SH; Kim YL; Kim CD
Transplant Proc; 2012 Jan; 44(1):200-3. PubMed ID: 22310614
[TBL] [Abstract][Full Text] [Related]
23. Antibody-mediated rejection in heart transplant patients: long-term follow up of patients with high levels of donor-directed anti-DQ antibodies.
Ticehurst EH; Molina MR; Frank R; Kearns J; Lal P; Goldberg LR; Tsai D; Wald J; Kamoun M
Clin Transpl; 2011; ():409-14. PubMed ID: 22755439
[TBL] [Abstract][Full Text] [Related]
24. Multimodal therapy with combined plasmapheresis, photoapheresis, and intravenous immunoglobulin for acute antibody-mediated renal transplant rejection: a 2-year follow-up.
Lai Q; Pretagostini R; Gozzer M; Cinti P; Meo D; Vita F; Shafii Bafti M; Poli L; Novelli G; Rossi M; Girelli G; Berloco PB
Transplant Proc; 2011 May; 43(4):1039-41. PubMed ID: 21620047
[TBL] [Abstract][Full Text] [Related]
25. The Treatment of Antibody-Mediated Rejection in Kidney Transplantation: An Updated Systematic Review and Meta-Analysis.
Wan SS; Ying TD; Wyburn K; Roberts DM; Wyld M; Chadban SJ
Transplantation; 2018 Apr; 102(4):557-568. PubMed ID: 29315141
[TBL] [Abstract][Full Text] [Related]
26. Therapy Modalities for Antibody Mediated Rejection in Renal Transplant Patients.
Yilmaz VT; Suleymanlar G; Koksoy S; Ulger BV; Ozdem S; Akbas H; Akkaya B; Kocak H
J Invest Surg; 2016 Oct; 29(5):282-8. PubMed ID: 27002854
[TBL] [Abstract][Full Text] [Related]
27. Treatment of Antibody-Mediated Rejection After Kidney Transplantation - 10 Years' Experience With Apheresis at a Single Center.
Gubensek J; Buturovic-Ponikvar J; Kandus A; Arnol M; Lindic J; Kovac D; Rigler AA; Romozi K; Ponikvar R
Ther Apher Dial; 2016 Jun; 20(3):240-5. PubMed ID: 27312908
[TBL] [Abstract][Full Text] [Related]
28. Intensive plasmapheresis and intravenous immunoglobulin for treatment of antibody-mediated rejection after kidney transplant.
Ruangkanchanasetr P; Satirapoj B; Termmathurapoj S; Namkhanisorn K; Suaywan K; Nimkietkajorn V; Luesutthiviboon L
Exp Clin Transplant; 2014 Aug; 12(4):328-33. PubMed ID: 25095710
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic apheresis in renal transplantation; current practices.
Keith DS
J Clin Apher; 2014 Aug; 29(4):206-10. PubMed ID: 24863952
[TBL] [Abstract][Full Text] [Related]
30. Novelties in diagnostics and therapy of antibody mediated rejection.
Dragun D; Rudolph B
Nephrol Dial Transplant; 2007 Sep; 22 Suppl 8():viii50-viii53. PubMed ID: 17890264
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic analysis of acute vascular rejection cases after renal transplantation.
Shimizu T; Tanabe T; Omoto K; Ishida H; Tanabe K
Transplant Proc; 2012 Jan; 44(1):230-5. PubMed ID: 22310621
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of rituximab and intravenous immunoglobulin therapy in renal transplant recipients with chronic active antibody-mediated rejection.
Hong YA; Kim HG; Choi SR; Sun IO; Park HS; Chung BH; Choi BS; Park CW; Kim YS; Yang CW
Transplant Proc; 2012 Jan; 44(1):182-4. PubMed ID: 22310610
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic apheresis in kidney transplantation: a review of renal transplant immunobiology and current interventions with apheresis medicine.
Nishio-Lucar A; Balogun RA; Sanoff S
J Clin Apher; 2013 Feb; 28(1):56-63. PubMed ID: 23420595
[TBL] [Abstract][Full Text] [Related]
34. Late antibody-mediated rejection after heart transplantation following the development of de novo donor-specific human leukocyte antigen antibody.
Hodges AM; Lyster H; McDermott A; Rice AJ; Smith JD; Rose ML; Banner NR
Transplantation; 2012 Mar; 93(6):650-6. PubMed ID: 22245878
[TBL] [Abstract][Full Text] [Related]
35. Evolving experience of treating antibody-mediated rejection following lung transplantation.
Otani S; Davis AK; Cantwell L; Ivulich S; Pham A; Paraskeva MA; Snell GI; Westall GP
Transpl Immunol; 2014 Aug; 31(2):75-80. PubMed ID: 25004453
[TBL] [Abstract][Full Text] [Related]
36. The treatment of acute antibody-mediated rejection in kidney transplant recipients-a systematic review.
Roberts DM; Jiang SH; Chadban SJ
Transplantation; 2012 Oct; 94(8):775-83. PubMed ID: 23032865
[TBL] [Abstract][Full Text] [Related]
37. Experience with antibody-mediated rejection in kidney allograft recipients.
Wade E; Goral S; Kearns J; Pierce E; Trofe J; Bloom R; Kamoun M
Clin Transpl; 2006; ():439-46. PubMed ID: 18365401
[TBL] [Abstract][Full Text] [Related]
38. Late acute antibody mediated rejection after nine years of renal transplantation.
Halim MA; Al-Otaibi T; Al-Waheeb S; Tawab KA; El Kholy O; Nair P; Said T; Narayanan Nampoory MR
Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1111-4. PubMed ID: 21060182
[TBL] [Abstract][Full Text] [Related]
39. Posttransplant immunosuppression in highly sensitized patients.
Akalin E
Contrib Nephrol; 2009; 162():27-34. PubMed ID: 19001811
[TBL] [Abstract][Full Text] [Related]
40. Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options.
Kim M; Martin ST; Townsend KR; Gabardi S
Pharmacotherapy; 2014 Jul; 34(7):733-44. PubMed ID: 24753207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
